Breast Cancer Panel: A Case-Based Discussion on the Use of Targeted Therapies for Primary and Metastatic Disease:

Recently, exciting clinical data on targeted therapies in breast cancer have been presented, and changes in clinical practice are beginning to occur. This live panel discussion will feature real cases of breast cancer patients from the practices of key opinion leader oncology physician and nurse panelists. A well known oncology nurse breast specialist will moderate the event, leading each case discussion from initial diagnosis to actual clinical course, including treatment choices, side effects experienced and their management, and patients’ concerns. Questions posed to the audience and panelists will facilitate discussions and reinforce learning objectives.

Oncology Highlights 2006: Targeted Therapy for the Treatment of Breast Cancer:

A recent key advancement in the treatment of breast cancer has been the use of therapies directed against specific molecular targets involved in the processes of tumor cell growth, proliferation, and invasion. Recent clinical trial data have emerged on targeted therapies in the first-line treatment of metastatic breast cancer and the adjuvant treatment of HER2-positive primary breast cancer. These data will be reviewed and discussed in this case-based symposium.

The Evolution of Targeted Therapies for the Treatment of Breast Cancer:

The past decade has witnessed major advances in the treatment of breast cancer as targeted therapies have been incorporated into standard chemotherapy regimens. In this educational symposium, the rationale for targeting specific molecular pathways in breast cancer treatment will be reviewed, and results of recent clinical trials evaluating targeted agents in the treatment metastatic and primary breast cancer will be presented. Appropriate nursing management of patients receiving these therapies will also be discussed.